Sellas Life Sciences Group Inc (SLS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.92
• Market Cap: $774.78M
• EPS: $-0.27
• 52-Week High: $5.18
• 52-Week Low: $0.95

Market Sentiment

Sellas Life Sciences Group Inc currently has a Bullish sentiment score of 0.48.

About Sellas Life Sciences Group Inc

SELLAS Life Sciences Group Inc. is a forward-thinking biopharmaceutical company based in New York, specializing in the development of groundbreaking cancer immunotherapies designed to tackle various oncological indications. By leveraging the body's immune system to effectively combat cancer, Sellas is advancing a proprietary pipeline of innovative treatments that address pressing medical needs. With its strategic focus and commitment to revolutionizing cancer care, Sellas positions itself as ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sellas Life Sciences Group Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SLS pay dividends?

Sellas Life Sciences Group Inc (SLS) does not currently pay a regular dividend.

What is SLS's market cap?

Sellas Life Sciences Group Inc (SLS) has a market capitalization of $774.78M with a current stock price of $4.92.